<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39332806</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-4577</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Clinical nutrition ESPEN</Title><ISOAbbreviation>Clin Nutr ESPEN</ISOAbbreviation></Journal><ArticleTitle>Low visceral fat volume and hypoalbuminemia as prognostic markers in hospitalized patients with coronavirus disease 2019 during the omicron variant epidemic.</ArticleTitle><Pagination><StartPage>93</StartPage><EndPage>99</EndPage><MedlinePgn>93-99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnesp.2024.09.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-4577(24)01321-4</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">The rate of severe cases of coronavirus disease 2019 (COVID-19) has decreased since the Omicron variant became epidemic. Visceral fat volume was a risk factor for COVID-19 severity with prior prevalent variants, but whether visceral fat volume remains a risk factor for the Omicron variant is unclear. We investigated the associations of clinical factors including visceral fat volume with severity and mortality among hospitalized patients with COVID-19 during the Omicron variant epidemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-center retrospective cohort study conducted at the Teikyo University Hospital in Japan. We included hospitalized patients with COVID-19 during the Omicron variant epidemic who underwent computed tomography of the abdomen. Clinical data were obtained from the medical records and visceral fat area (VFA) was measured using a 3-dimensional image analysis system volume analyzer. Severity was determined by the presence or absence of oxygen supplementation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 226 patients, 66 patients showed moderate severity and 29 patients were non-survivors. Hypoalbuminemia was associated with severity (odds ratio [OR] 3.93, 95 % confidence interval [CI] 1.91-8.07; p = 0.0002), and hypoalbuminemia (OR 8.38, 95%CI 2.37-29.58; p = 0.0010) and low VFA (OR 3.40, 95%CI 1.15-10.06; p = 0.027) were associated with mortality. Decision tree analysis showed that mortality rate in the hypoalbuminemia and low-VFA group (37.3 %) was significantly higher than in other groups (p ≤ 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Low visceral fat volume and hypoalbuminemia were associated with mortality in hospitalized patients with COVID-19 during the Omicron variant epidemic. Classification by VFA and serum albumin may allow simple prediction of mortality risk among hospitalized patients with COVID-19.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Shin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University, Itabashi-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakabayashi</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University, Itabashi-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawase</LastName><ForeName>Kyotaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University, Itabashi-ku, Tokyo, Japan; Department of Infectious Diseases, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University, Itabashi-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitazawa</LastName><ForeName>Takatoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University, Itabashi-ku, Tokyo, Japan. Electronic address: tkitazaw@med.teikyo-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr ESPEN</MedlineTA><NlmUniqueID>101654592</NlmUniqueID><ISSNLinking>2405-4577</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Serum albumin</Keyword><Keyword MajorTopicYN="N">Visceral fat area</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39332806</ArticleId><ArticleId IdType="doi">10.1016/j.clnesp.2024.09.016</ArticleId><ArticleId IdType="pii">S2405-4577(24)01321-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle>